The R&D budget for Health and Society in Japan, expressed as a percentage of total government support, is expected to show steady growth from 2024 to 2028. Forecasted values start from 5.92 in 2024 to 6.3 in 2028, indicating a consistent upward trajectory. The year-on-year growth is approximately 1.69% for this period. In comparison to the last two years, this represents a positive trend, with growth insights reflecting a compound annual growth rate (CAGR) of around 1.57% over the five-year period.
Future trends to watch for include heightened government focus on healthcare innovation, potential policy shifts impacting funding flows, and any global economic factors that could affect budget allocations. Keeping track of technological advancements and societal needs will be crucial in anticipating further changes in R&D investments.